DUBLIN, March 16, 2023 /PRNewswire/ — The “DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.
The global DNA sequencing products market size reached US$ 6.3 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 11.4 Billion by 2028, exhibiting a CAGR of 10.39% during 2022-2028.
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Pacific Biosciences of California Inc.
- Beckman Coulter
DNA sequencing is the process used for calculating the precise sequence of the four nucleotide bases within a DNA molecule, namely, cytosine, adenine, thymine and guanine. It plays an important role in mapping out the human genome as well as helps in various applied research applications.
In line with this, DNA sequencing products are gaining popularity in the pharmaceutical industry as they assist researchers in understanding complex diseases and, in turn, develop personalised medicines for patients. Additionally, DNA profiling has become an integral part of forensic science as these profiles enable investigators to identify and distinguish multiple samples from a pool of DNA.
Genome mapping and sequencing of microorganisms have enabled agriculturists to use them for crops and food plants. Over the past few years, specific genes of bacteria have been used in food plants to improve their resistance against insects and pests which has increased their productivity and nutritional value.
In addition to this, genomes of several domesticated livestock animals, such as chicken, pig, cow, sheep, and horse, have also been partially or completely sequenced and proven to be useful in the production of livestock with enhanced quality of meat and milk.
The role of DNA sequencing in the in-vitro diagnostics market, particularly for point-of-care diagnostics, is expected to gain momentum. DNA sequencing enables the development of precision medicine in order to offer specific treatments or therapies to patients. It also provides various platforms that enable genetic sequencing and analysis of DNA data at the point-of-care with high accuracy and rapid diagnosis.
Researchers and instrument developers have produced an array of DNA sequencing technologies which offer faster sequencing with higher accuracy at lower costs. For instance, one of the primary market players in the field, Illumina, has launched a system that consists of 10 ultra-high-throughput sequencers and can sequence about 18,000 human genomes per year.
Researchers are now using innovative technologies for genome mapping that take lesser time for completion. Other than this, the reduction in sequencing costs has led many companies to invest in R&D activities and offer cost-effective solutions such as whole genome sequencing, de novo sequencing and specific disease diagnosis.
Key Questions Answered in This Report
1. What was the size of the global DNA sequencing products market in 2022?
2. What is the expected growth rate of the global DNA sequencing products market during 2023-2028?
3. What are the key factors driving the global DNA sequencing products market?
4. What has been the impact of COVID-19 on the global DNA sequencing products market?
5. What is the breakup of the global DNA sequencing products market based on the product type?
6. What is the breakup of the global DNA sequencing products market based on the application?
7. What is the breakup of the global DNA sequencing products market based on the end-user?
8. What are the key regions in the global DNA sequencing products market?
9. Who are the key players/companies in the global DNA sequencing products market?
Key Topics Covered:
2 Scope and Methodology
3 Executive Summary
4.2 Key Industry Trends
5 Global DNA Sequencing Products Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product Type
5.5 Market Breakup by Application
5.6 Market Breakup by End-User
5.7 Market Breakup by Technology
5.8 Market Breakup by Region
5.9 Market Forecast
5.10 SWOT Analysis
5.11 Value Chain Analysis
5.12 Porters Five Forces Analysis
6 Market Breakup by Product Type
6.1 Consumables and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1.1 Market Trends
7.1.2 Market Forecast
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Reproductive Health
7.3.1 Market Trends
7.3.2 Market Forecast
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Personalized Medicine
7.5.1 Market Trends
7.5.2 Market Forecast
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End-User
8.1 Academic and Government Research Institutes
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmaceutical and Biotechnology Companies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Hospitals and Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
10 Competitive Landscape
10.1 Market Structure
10.2 Market Breakup by Key Players
10.3 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/f3xb5z
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Originally published at https://www.prnewswire.com/news-releases/dna-sequencing-products-global-market-report-2023-sector-to-reach-11-4-billion-by-2028-at-a-cagr-of-10-39-301773993.html